A predictive signature based on enhancer RNA associates with immune infiltration and aids treatment decision in clear cell renal cell carcinoma

A predictive signature based on enhancer RNA associates with immune infiltration and aids treatment decision in clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) is a prevalent urinary malignancy. Despite the recent development of better diagnostic tools and therapy, the five-year survival rate for individuals with advanced and metastatic ccRCC remains dismal. Unfortunately, ccRCC is less susceptible to radiation and c...

Full description

Bibliographic Details
Main Authors: Qinyu Li, Xueyan Xiao, Bingliang Chen, Guoda Song, Kai Zeng, Beining Li, Jianping Miao, Chaofan Liu, Yang Luan, Bo Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
clear cell renal cell carcinoma
drug sensitivity
enhancer RNA
immunotherapy
treatment decision
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.964838/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.964838/full

Similar Items